UTI AMC Slips After Q4 Shocker — What Investors Should Note

shares fell 10.66% on 24 April 2026 following its Q4 results. The company reported a consolidated loss of ₹51.44 crore, compared to a profit of ₹101.99 crore in the same period last year. Despite the earnings setback, revenue showed resilience, rising 3.8% YoY to ₹390.3 crore from ₹375.9 crore. On the shareholder front, the board has recommended a final dividend of ₹40 per share, offering some support to investor sentiment. The stock closed at ₹925.25. Technically, the ₹905–₹890 zone is emerging as an important support band, making upcoming sessions worth tracking for market behavior. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.